Dushan Petkovski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dushan Petkovski has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ana Chelikikj
University Clinic of Cardiology Skopje
1 shared publication - Elena Grueva
University Clinic of Cardiology - Skopje
1 shared publication - Elma Kandic
University Clinic of Cardiology - Skopje
1 shared publication - Enes Shehu1 shared publication
- Irena Mitevska
Clinic of Cardiology, Clinical Center Skopje, Skopje, North Macedonia; Faculty of Medicine, Ss. Cyril and Methodius University in Skopje, Skopje, North Macedonia, North Macedonia
1 shared publication - Irina Kotlar Velkova1 shared publication
Latest Publications
- 14 May 2025
- Published by SAGE Publications in Wilderness & Environmental Medicine
- Vol. 36 (3) , 389-396
Delayed Treatment of Misdiagnosed Mushroom Poisoning: Do Organic Anion Transporting Polypeptide Substrates Matter?
A middle-aged male was admitted to the clinic 4 d after ingestion of wild mushrooms. His medical history included type 2 diabetes, hypertension, and coronary bypass. Initially misdiagnosed with infectious enterocolitis, the patient was treated as an outpatient with intravenous fluids while continuing his chronic medications (i.e., statins, beta-blockers, and aspirin). On Day 3, blood tests confirmed hepatorenal syndrome, and the patient was transferred to the clinic. On admission, he was alert with a blood pressure of 100/60 mmHg, heart rate of 100 beats/min, sinus rhythm, right upper quadrant pain, and jaundice. Lab results showed thrombocytopenia, severe hepatorenal dysfunction, prolonged prothrombin time (29.3 s), and a Model for End-Stage Liver Disease score of 30. For 3 d, the patient was simultaneously exposed to amatoxin and chronic cardiovascular medications, both substrates for the same transporters. Treatment was adjusted to intravenous acetylcysteine (double regimen), oral silymarin (600 mg/d), and supportive therapy. The patient recovered within 10 d, with transaminases normalizing after 3 mo. Understanding transporter-related drug interactions and patient-specific metabolic differences may improve future management strategies and patient survival. Further research is needed on alternative inhibitors of amatoxin uptake and competitive organic anion-transporting polypeptide substrates to expand treatment options.
- 14 May 2025
- Published by SAGE Publications in Wilderness & Environmental Medicine
- Vol. 36 (3) , 389-396
Delayed Treatment of Misdiagnosed Mushroom Poisoning: Do Organic Anion Transporting Polypeptide Substrates Matter?
A middle-aged male was admitted to the clinic 4 d after ingestion of wild mushrooms. His medical history included type 2 diabetes, hypertension, and coronary bypass. Initially misdiagnosed with infectious enterocolitis, the patient was treated as an outpatient with intravenous fluids while continuing his chronic medications (i.e., statins, beta-blockers, and aspirin). On Day 3, blood tests confirmed hepatorenal syndrome, and the patient was transferred to the clinic. On admission, he was alert with a blood pressure of 100/60 mmHg, heart rate of 100 beats/min, sinus rhythm, right upper quadrant pain, and jaundice. Lab results showed thrombocytopenia, severe hepatorenal dysfunction, prolonged prothrombin time (29.3 s), and a Model for End-Stage Liver Disease score of 30. For 3 d, the patient was simultaneously exposed to amatoxin and chronic cardiovascular medications, both substrates for the same transporters. Treatment was adjusted to intravenous acetylcysteine (double regimen), oral silymarin (600 mg/d), and supportive therapy. The patient recovered within 10 d, with transaminases normalizing after 3 mo. Understanding transporter-related drug interactions and patient-specific metabolic differences may improve future management strategies and patient survival. Further research is needed on alternative inhibitors of amatoxin uptake and competitive organic anion-transporting polypeptide substrates to expand treatment options.
- 1 April 2025
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 20 (3-4) , 76-83
Capecitabine-induced Cardiotoxicity Complicated with Acute Coronary Syndrome and Acute Heart Failure: A Case Report and Review of Scientific Data
- 1 April 2025
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 20 (3-4) , 76-83
Capecitabine-induced Cardiotoxicity Complicated with Acute Coronary Syndrome and Acute Heart Failure: A Case Report and Review of Scientific Data